日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium

一项针对转移性肾细胞癌患者的真实世界研究比较了纳武利尤单抗联合卡博替尼和帕博利珠单抗联合乐伐替尼的安全性结果:来自 JK-FOOT 联盟的研究结果

Yanagisawa, Takafumi; Mori, Keiichiro; Kawada, Tatsushi; Katayama, Satoshi; Tsujino, Takuya; Maenosono, Ryoichi; Toyoda, Shingo; Nukaya, Takuhisa; Morinaka, Hirofumi; Tamura, Keita; Fukuokaya, Wataru; Urabe, Fumihiko; Murakami, Masaya; Bekku, Kensuke; Takahara, Kiyoshi; Fujita, Kazutoshi; Azuma, Haruhito; Araki, Motoo; Inamoto, Teruo; Komura, Kazumasa; Kimura, Takahiro

Comparative efficacy of immune checkpoint inhibitor combination therapies by metastatic site in metastatic renal cell carcinoma

转移性肾细胞癌中免疫检查点抑制剂联合疗法疗效的比较(按转移部位划分)

Toyoda, Shingo; Inoki, Lan; Hashimoto, Mamoru; Fukuokaya, Wataru; Mori, Keiichiro; Nishimura, Shingo; Maenosono, Ryoichi; Iwata, Takehiro; Bekku, Kensuke; Nukaya, Takuhisa; Yanagisawa, Takafumi; Tsujino, Takuya; Komura, Kazumasa; Takahara, Kiyoshi; Inamoto, Teruo; Azuma, Haruhito; Fujita, Kazutoshi

Penile involvement associated with renal pelvic squamous cell carcinoma: a case report and mechanistic considerations

肾盂鳞状细胞癌并发阴茎受累:病例报告及机制探讨

Masaki, Kotaro; Tsujino, Takuya; Okada, Hiroyuki; Yoshikawa, Yuki; Maenosono, Ryoichi; Imura, Yusaku; Sanada, Masashi; Hirosuna, Kensuke; Furusawa, Yuta; Yoshimi, Rei; Kojima, Issei; Sakamoto, Moritoshi; Iwatsuki, Kengo; Nakajima, Yuki; Matsuda, Takuya; Higashio, Takuya; Tsuchida, Shuya; Yamazaki, Shogo; Nakamura, Ko; Fukushima, Tatsuo; Nishimura, Kazuki; Nakamori, Keita; Tsutsumi, Takeshi; Matsunaga, Tomohisa; Azuma, Haruhito

The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI Therapy

一线ARPI治疗治疗转移性激素敏感性前列腺癌患者中,PSA无进展但影像学进展的预后意义

Tsutsumi, Takeshi; Yamazaki, Shogo; Matsuda, Takuya; Tsujino, Takuya; Uchimoto, Taizo; Yanagisawa, Takafumi; Mori, Keiichiro; Fukuokaya, Wataru; Fumihiko Urabe; Saruta, Masanobu; Yoshizawa, Atsuhiko; Toyoda, Shingo; Fujimoto, Saizo; Nishio, Kyosuke; Sakamoto, Moritoshi; Fukushima, Tatsuo; Nakamura, Ko; Nishimura, Kazuki; Nakamori, Keita; Matsunaga, Tomohisa; Yoshikawa, Yuki; Maenosono, Ryoichi; Takahara, Kiyoshi; Inamoto, Teruo; Kimura, Takahiro; Fujita, Kazutoshi; Komura, Kazumasa; Azuma, Haruhito

Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapy

嗜酸性粒细胞作为一线免疫检查点抑制剂联合疗法治疗转移性肾细胞癌患者治疗相关不良事件的预测标志物

Kawada, Tatsushi; Katayama, Satoshi; Yanagisawa, Takafumi; Mori, Keiichiro; Fukuokaya, Wataru; Komura, Kazumasa; Tsujino, Takuya; Maenosono, Ryoichi; Takahara, Kiyoshi; Nukaya, Takuhisa; Inoki, Lan; Toyoda, Shingo; Hashimoto, Takeshi; Hirasawa, Yosuke; Edamura, Kohei; Kobayashi, Tomoko; Bekku, Kensuke; Nishimura, Shingo; Iwata, Takehiro; Sadahira, Takuya; Tominaga, Yusuke; Yamanoi, Tomoaki; Yoshinaga, Kasumi; Tsuboi, Kazuma; Kobayashi, Yasuyuki; Takamoto, Atsushi; Kurose, Kyohei; Kimura, Takahiro; Azuma, Haruhito; Shiroki, Ryoichi; Fujita, Kazutoshi; Ohno, Yoshio; Araki, Motoo

Vesical perfusion volume and internal iliac pressure during double balloon-occluded arterial infusion chemotherapy for bladder cancer

膀胱癌双球囊阻断动脉灌注化疗期间的膀胱灌注量和髂内压

Yamamoto, Kiyohito; Yamamoto, Kazuhiro; Juri, Hiroshi; Azuma, Haruhito; Osuga, Keigo

Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors

采用雄激素受体信号抑制剂治疗转移性激素敏感性前列腺癌患者的PSA动态变化及肿瘤学结果特征

Yamada, Yasutaka; Sato, Kodai; Sakamoto, Shinichi; Tsujino, Takuya; Saito, Sinpei; Nishimura, Kazuki; Fukushima, Tatsuo; Nakamura, Ko; Yoshikawa, Yuki; Matsunaga, Tomohisa; Maenosono, Ryoichi; Kanesaka, Manato; Arai, Takayuki; Sazuka, Tomokazu; Imamura, Yusuke; Komura, Kazumasa; Mikami, Kazuo; Nakamura, Kazuyoshi; Fukasawa, Satoshi; Chiba, Kazuto; Naya, Yukio; Nagata, Maki; Komaru, Atsushi; Nakatsu, Hiroomi; Azuma, Haruhito; Ichikawa, Tomohiko

Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer

转移性激素敏感性前列腺癌中原发肿瘤进展的临床意义

Yamada, Yasutaka; Sakamoto, Shinichi; Tsujino, Takuya; Saito, Sinpei; Sato, Kodai; Nishimura, Kazuki; Fukushima, Tatsuo; Nakamura, Ko; Yoshikawa, Yuki; Matsunaga, Tomohisa; Maenosono, Ryoichi; Kanesaka, Manato; Arai, Takayuki; Sazuka, Tomokazu; Imamura, Yusuke; Komura, Kazumasa; Mikami, Kazuo; Nakamura, Kazuyoshi; Fukasawa, Satoshi; Chiba, Kazuto; Naya, Yukio; Nagata, Maki; Komaru, Atsushi; Nakatsu, Hiroomi; Azuma, Haruhito; Ichikawa, Tomohiko

Upper urinary tract urothelial carcinoma patients show better overall response rate than bladder cancer patients during enfortumab vedotin treatment following pembrolizumab

在接受帕博利珠单抗治疗后,接受恩福妥单抗治疗的上尿路尿路上皮癌患者的总体缓解率优于膀胱癌患者。

Hashimoto, Mamoru; Fukiage, Ken; Taniguchi, Kosei; Minami, Takafumi; Fukuokaya, Wataru; Mori, Keiichiro; Yanagisawa, Takafumi; Tsujino, Takuya; Maenosono, Ryoichi; Saruta, Masanobu; Takahara, Kiyoshi; Hashimoto, Takeshi; Hirasawa, Yosuke; Azuma, Haruhito; Ohno, Yoshio; Shiroki, Ryoichi; Fujita, Kazutoshi

Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinoma.

PD-L1抑制剂在转移性尿路上皮癌中诱发致命性超进展疾病的机制研究

Nishimura Kazuki, Takahara Kiyoshi, Komura Kazumasa, Ishida Mitsuaki, Hirosuna Kensuke, Maenosono Ryoichi, Ajiro Masahiko, Sakamoto Moritoshi, Iwatsuki Kengo, Nakajima Yuki, Tsujino Takuya, Taniguchi Kohei, Tanaka Tomohito, Inamoto Teruo, Hirose Yoshinobu, Ono Fumihito, Kondo Yoichi, Yoshimi Akihide, Azuma Haruhito